Journey Medical Corporation (DERM)
NASDAQ: DERM · Real-Time Price · USD
4.330
-0.060 (-1.37%)
At close: Nov 13, 2026, 4:00 PM EST
4.335
+0.005 (0.12%)
After-hours: Nov 13, 2026, 7:30 PM EST
Journey Medical Market Cap
Journey Medical has a market cap or net worth of $122.21 million as of November 13, 2026. It is the 23,609th most valuable company in the world and the 3,898th biggest in the United States. Its market cap has decreased by 50.40% in one year.
Market Cap
122.21M
Enterprise Value
125.51M
1-Year Change
-50.40%
Global Rank
Country Rank
#3,898 United States
Category
ChartMarket Cap Chart
Since the IPO on November 12, 2021, Journey Medical's market cap has decreased from $157.79M to $122.21M, a decrease of -22.55%. That is a compound annual growth rate of -4.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 122.21M | -41.59% |
| Dec 31, 2025 | 209.22M | 156.14% |
| Dec 31, 2024 | 81.68M | -23.38% |
| Dec 29, 2023 | 106.61M | 212.54% |
| Dec 30, 2022 | 34.11M | -61.94% |
| Dec 31, 2021 | 89.63M | -43.20% |
| Nov 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SIGA Technologies | 225.62M |
| ADC Therapeutics | 225.06M |
| Anika Therapeutics | 186.86M |
| Glass House Brands | 176.23M |
| Akebia Therapeutics | 159.30M |
| Organogenesis Holdings | 136.29M |
| Organigram Global | 119.80M |
| Cardiol Therapeutics | 119.76M |